Shares of Threshold Pharmaceuticals Inc. (Nasdaq: THLD) continued rising by climbing 76 cents to $3.75 after announcing a partnership with Merck on Friday to co-develop and commercialize its cancer treatment TH-302.
Threshold Continues Rising
February 06, 2012 at 13:33 PM EST
